You have read all your free articles, to continue reading subscribe to read the rest of this content.
Zerion Pharma and the Spanish pharmaceutical group Insud Pharma will develop and commercialize drug products applying ZERION’s Dispersome technology. Zerion will develop Dispersome formulations of marketed drug products while Insud will be responsible for the finished product dosage form, the cAlready a subscriber Login You have read all your free…
The global pharmaceutical company Organon is acquiring its portfolio company Forendo Pharma. Forendo Pharma's shareholders will receive an initial payment of USD 75 million and are entitled to additional future payments totaling USD 870 million upon the achievement of certain development, registrAlready a subscriber Login You have read all your…
Bio-Me has raised NOK 10 million in a fully subscribed funding round. Both existing and new investors participated in the financing round, with new investors contributing the majority of the capital, states the company in a press release. "We are excited to move forward with our plans to achieveAlready a…
Athera Biotechnologies has completed a 57 million SEK financing from current major owners, The Foundation for Baltic and East European Studies (Östersjöstiftelsen), Industrifonden and Linc AB, together with new investor Ribbskottet AB, an investment company lead by Anders Bladh. Mr Bladh has a Already a subscriber Login You have read…
